Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

University of Oxford researchers from the Department of Physiology, Anatomy and Genetics (DPAG) and the Department of Psychiatry, in collaboration with The 1928 Institute, have published a major new study on the impact of COVID-19 on the UK’s largest BME population.

A medical professional wearing a mask and safety gloves prepares COVID-19 Vaccine

The new study has shed light on the willingness of British Indians to take a COVID-19 vaccine (56%) and the impact of the pandemic on the health and culture of the Indian diaspora in the UK. 

The 1928 Institute, a think tank co-founded by Dr Nikita Ved, Department of Physiology, Anatomy and Genetics (DPAG), and Kiran Kaur Manku, Department of Psychiatry, are working together to research and represent the views of British Indians – the UK’s largest ethnic minority group. 

Researchers have been working on two projects with the University of Oxford: The British Indian Census; a seminal piece of work for the British Indian community, and Pulse & Policy; short, topical surveys designed to poll the community on timely and pressing issues.  

This new COVID-19 report is a culmination of all COVID-19 related data from these projects, findings include: 

  • Only 56% of British Indians would take a COVID-19 vaccine when offered, which is significantly lower than the national average of 79%
  • Women are significantly less likely than men to take a vaccine with 52% of women willing to take the vaccine, compared with 63% of men. 
  • 19% of British Indians feel that other people should have priority in receiving a vaccine, specifically those who are vulnerable and those in Low- and Middle-Income Countries.
  • 75% of British Indians face barriers in accessing mental healthcare, and men in particular have overwhelming concerns of suicide. 

The full story is available on the Department of Physiology, Anatomy & Genetics website, and also the Department of Psychiatry website.

Similar stories

Wellcome accolades for Dr Douglas

Dr Alexander (Sandy) Douglas, an investigator at the Jenner Institute, Nuffield Department of Medicine, has recently received two prestigious Wellcome accolades.

FOCUS4: a flagship trial in colorectal cancer

Professor Tim Maughan (Department of Oncology) outlines the flagship work of the FOCUS4 trials, whose results were presented last weekend at the European Society of Medical Oncology (ESMO) annual meeting

Oxford and Oracle partner to speed identification of COVID-19 variants

The fast spread of the highly infectious Delta variant underscores the need for faster identification of COVID-19 mutations. Uniting governments and medical communities in this challenge, the University of Oxford and Oracle’s Global Pathogen Analysis System (GPAS) is now being used by organizations on nearly every continent. Institutions using the platform include: the University of Montreal Hospital Centre Research Centre, the Institute of Public Health Research of Chile, the Oxford University Clinical Research Unit in Vietnam, the Institute of Clinical Pathology and Medical Research – New South Wales Pathology, and Oxford Nanopore Technologies. GPAS is also now part of the Public Health England New Variant Assessment Platform.

Vaccinated groups at highest risk of Covid-19 hospitalisation and death identified using new QCovid tool

Researchers from the University of Oxford have today reported on findings on the vaccinated people who are at greatest risk from severe Covid-19 leading to hospitalisation or death from 14 days post the second dose vaccination, when substantial immunity should be expected.

Com-COV vaccine mix-and-match study expands to 12-to-16-year-olds

Researchers running the University of Oxford-led Com-COV programme have launched a new study of COVID-19 vaccination schedules in young people aged 12 to 16.